Harrow HROW
NASDAQ HROW
$42.20 +0.56 (+1.34%)
At close: Aug 20, 2026 · 12:40 PM UTC

Harrow (HROW) Capital Leases (2014 - 2022)

Harrow (HROW) posted quarterly Capital Leases of $7000.0 for Q1 2022, down 56.25% year-over-year from $16000.0 in Q1 2021, and down 30.0% quarter-over-quarter from $10000.0 in Q4 2021.

Harrow (HROW) Capital Leases (2014 - 2022) Analysis & Trends

Harrow's Capital Leases history runs 9 years deep, the most recent figure standing at $7000.0 for Q1 2022.

  • In Q1 2022, Capital Leases fell 56.25% year-over-year to $7000.0; the TTM figure through Mar 2022 stood at $7000.0 (down 56.25% YoY), while the FY2021 annual figure was $10000.0, down 41.18% from the prior year.
  • Capital Leases for Q1 2022 stood at $7000.0, down from $10000.0 in the prior quarter.
  • The five-year high for Capital Leases was $546000.0 in Q1 2018, with the low at $7000.0 in Q1 2022.
  • The 5-year median for Capital Leases is $22000.0 (2020), against an average of $77800.0.
  • The sharpest annual moves came in 2019 and 2020: Capital Leases plunged 94.14% in 2019, then decreased 24.14% in 2020.
  • Harrow's Capital Leases stood at $363000.0 in 2018, then plunged by 92.84% to $26000.0 in 2019, then tumbled by 34.62% to $17000.0 in 2020, then sank by 41.18% to $10000.0 in 2021, then fell by 30.0% to $7000.0 in 2022.
  • Business Quant data shows HROW's Capital Leases at $7000.0 in Q1 2022, $10000.0 in Q4 2021, and $12000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Harrow 1.58 Bn 1.49 Bn 50.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2022 7,000.00
Dec 31, 2021 10,000.00
Sep 30, 2021 12,000.00
Jun 30, 2021 14,000.00
Mar 31, 2021 16,000.00
Dec 31, 2020 17,000.00
Sep 30, 2020 20,000.00
Jun 30, 2020 22,000.00
Mar 31, 2020 24,000.00
Dec 31, 2019 26,000.00
Sep 30, 2019 29,000.00
Jun 30, 2019 29,000.00
Mar 31, 2019 32,000.00
Jun 30, 2018 363,000.00
Mar 31, 2018 546,000.00
Dec 31, 2017 720,000.00
Sep 30, 2017 883,000.00
Jun 30, 2017 1.04 Mn
Mar 31, 2017 1.18 Mn
Dec 31, 2016 1.32 Mn